Role of Heterogeneous Regulatory T Cells in the Tumor Microenvironment

Publication date: Available online 23 January 2020Source: Pharmacological ResearchAuthor(s): Ting Wei, Weijie Zhong, Qingshan LiAbstractRegulatory T cells (Tregs) modulate ongoing immune responses to prevent autoimmunity in healthy bodies and inhibit effective anti-tumor immunity responses in tumor patients, leading to tumor progression. The function of Tregs in tumor immunity suggests that elimination of Tregs in the host may enhance the anti-tumor immune response. Despite the success of strategies for depleting Tregs in tumor-bearing patients, the overall clinical efficacy is limited and accompanied by undesirable side effects. The present review describes the diverse anti-tumor roles and differentiation mechanisms of heterogeneous Tregs and proposes methods for modulating them in the tumor microenvironment. This information is critical for improving clinical outcomes and preventing adverse effects in cancer patients receiving immunotherapy targeting Tregs.Graphical abstract
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research